| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.19 | 0.004 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.15 | 0.004 |